Covid-19 Vaccine race @INDIA

We all know that INDIA acts as Pharma Supplier to the world in times of Corona   Pandemic .

As scientists are edge closer to creating a vaccine against the coronavirus, Indian pharmaceutical companies are front and centre in the race to supply the world with an effective product.Indian Pharma companies are major manufacturers of vaccines distributed worldwide, particularly those for low-income countries, supplying more than 60% of vaccines supplied to the developing world. Because of this, they are likely to gain early access to any COVID19 vaccine that works.

As we know Russia Made First vaccine Sputnik V Ahead of US.

Like wise India is also Developing Own vaccine with Own conditions.

Here are the Companies  which were in the race of Manufacturing Indian COVID19 vaccine

1.SERUM INSTITUTE OF INDIA

    Proud to say that it is a leading Vaccine Manufacturing company in the world. SII working with oxford University to develop vaccine for corona virus.It is conducting Phase II+III clinical trials of Oxford University-Astra Zeneca COVID19 vaccine COVISHIELD.

2.BHARAT BIOTECH

COVAXIN, India's indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV). The indigenous, inactivated vaccine is developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) high containment facility Hyderabad.It is Conducting its PHASE-III Trials.

3.ZYDUS CADILA 

Cadila's vaccine candidate, known as ZyCov-D . India's Zydus Cadila plans to complete late-stage trials for its novel coronavirus vaccine candidate by February or March and could produce up to 100 million doses a year initially if it is successful.It is a bit premature right now, and It's in stage of Phase 1 and 2 trials.

4.BIOLOGICAL E

Biological E. Limited (BE), a Hyderabad-based vaccines and pharmaceutical company, Dynavax Technologies Corporation (Dynavax), a US-based vaccine focused biopharmaceutical company, and Baylor College of Medicine, a health sciences university in Houston is initiated a Phase I/II clinical trial of its COVID-19 subunit vaccine candidate in India.

5.MYNVAX

MYNVAX startup company incubated in the Indian Institute of Science (IISc), Bengaluru, is developing a Covid-19 vaccine that can be stored at 37 degrees Celsius, a development that could be a game changer for India which lacks sufficient cold chain facilities.

Along with development of vaccine in India. It have to prepare for Distribution of Vaccine to each and every corner of country by strengthening its Cold storage facilities,Cold chain supply ,consumables for vaccine like Syringes ,Vials Etc.

Its not Easy to vaccinate whole India with 130 Crore Population, it may take Years to last person to get his last shot of COVID19 vaccine.

You can also find the following (click on the following titles)

I- Choose your mask @ COVID-19

II- Covid-19 Vaccine Salvation from Pandemic